Product Development

Having seen the potential effect of this treatment, we are ready for the next step of drug development!

  • Discovery and Initial Proof of Concept

​

  • Preclinical Product Development

​

  • Clinical Trials

​

  • Commercialization

we are here!

Drug Development Process

1.png
2.png
3.png
4.png
5.png
6.png

Watch Shock Biotech's Founder Dr. Donald Gann Describe This Novel Discovery and Treatment! 

STBI is currently seeking capital to fund this development program as we work towards the clinic and IND approval over the next ~2 years.

Meet the Team Dedicated to this Project

info@shockbiotech.com

1100 Wicomico Street

Baltimore, MD 21230

  • LinkedIn Social Icon
  • Twitter Social Icon
  • Facebook Social Icon

© 2020 Shock Therapeutics Biotechnologies, Inc.

Proudly Founded & Headquartered in Baltimore, Maryland